Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Splenic marginal zone lymphoma with increased prolymphocytes

Jennifer Cai, Xin Qing

Blood (2021) 137 (22): 3150.

https://doi.org/10.1182/blood.2021011533

Published: 2021

Journal Articles

Genetic Characterization of B-Cell Prolymphocytic Leukemia (B-PLL): A Hierarchical Prognostic Model Involving MYC and TP53 Abnormalities. on Behalf of the Groupe Francophone De Cytogenetique Hematologique (GFCH) and the French Innovative Leukemia Organization (FILO) Group

Blood (2018) 132 (Supplement 1): 943.

https://doi.org/10.1182/blood-2018-99-115085

Published: 2018

Journal Articles

An Artificial Intelligence (AI) Approach for Automated Flow Cytometric Diagnosis of B-Cell Lymphoma

Alexander Höllein, MD, Max Zhao, Richard Schabath, MD, Torsten Haferlach, MD, Claudia Haferlach, MD, Peter Krawitz, MD, Wolfgang Kern, MD

Blood (2018) 132 (Supplement 1): 2856.

https://doi.org/10.1182/blood-2018-99-113797

Published: 2018

Journal Articles

B-Cell Prolymphocytic Leukemia, a Rare Lymphoproliferative Disorder: Analysis of 35 Cases, a Study on Behalf of the French Innovative Leukemia Organization (FILO)

Caroline Algrin, Elise Chapiro, Justine Saviellis, Anne Quinquenel, Anne-Sophie Michallet, MD PhD, David Ghez, MD PhD, Pierre Feugier, MD, Annie Brion, Cecile Tomowiak, MD, Luc-Matthieu Fornecker, Remy Gressin, MD, Laurent Sutton, MD, Karim Maloum, Catherine Settegrana, Lucile Baseggio, MD, Quentin Vincent, Florence Nguyen-Khac, MD PhD, Véronique Leblond

Blood (2017) 130 (Supplement 1): 4310.

https://doi.org/10.1182/blood.V130.Suppl_1.4310.4310

Published: 2017

Journal Articles

PD-1 Expression in Chronic Lymphocytic Leukemia and Large B-Cell Richter Transformation (DLBCL-RT): A Distinguishing Feature for DLBCL-RT and Promising Surrogate Marker for Clonal Relatedness

Rong He, MD, Wei Ding, MD PhD, David Viswanatha, MD, Dong Chen, MD PhD, Min Shi, MD PhD, Daniel L. Van Dyke, PhD, Linda N Dao, MD, Sameer A. Parikh, MD, Tait D Shanafelt, MD, Timothy G. Call, MD, Stephen M Ansell, MD PhD, Jose F. Leis, MD PhD, Ming Mai, MS, Curtis A. Hanson, MD, Karen L Rech, MD

Blood (2017) 130 (Supplement 1): 4286.

https://doi.org/10.1182/blood.V130.Suppl_1.4286.4286

Published: 2017

Journal Articles

The Contribution of Gene Mutations to Long-Term Clinical Outcomes: Data from the Randomised UK LRF CLL4 Trial

Blood (2017) 130 (Supplement 1): 259.

https://doi.org/10.1182/blood.V130.Suppl_1.259.259

Published: 2017

Journal Articles

Overcoming Ibrutinib Resitance In Relapsed Chronic Lymphocytic Leukemia

Kamal Sharma, DO, August Stuart, MS, Elliot M Epner, MD, PhD, Thomas P. Loughran, Jr., MD

Blood (2013) 122 (21): 4891.

https://doi.org/10.1182/blood.V122.21.4891.4891

Published: 2013

Journal Articles

Diagnostic Value of CD200 Expression for the Differentiation Between Chronic Lymphocytic Leukemia (CLL), CLL with Increased Prolymphocytes (CLL/PL) and Mantle Cell Lymphoma.

Wolfgang Kern, MD, Richard Schabath, Claudia Haferlach, MD, Susanne Schnittger, PhD, Torsten Haferlach, MD

Blood (2012) 120 (21): 2660.

https://doi.org/10.1182/blood.V120.21.2660.2660

Published: 2012

Journal Articles

Characteristics and Prognosis of Patients with Aggressive Chronic Lymphocytic Leukemia and Richter's Transformation: Correlation Between FDG/PET, Histology and Clinical Outcomes

Lorenzo Falchi, MD, Long Xuan Trinh, Edith M. Marom, MD, Mylene Truong, MD, Ellen Schlette, MD, Rachel L. Sargent, MD, Xuemei Wang, MS, Susan C. Smith, Susan Lerner, MS, Michael J. Keating, MD, Alessandra Ferrajoli, MD

Blood (2012) 120 (21): 927.

https://doi.org/10.1182/blood.V120.21.927.927

Published: 2012

Journal Articles

Chronic Lymphocytic Leukemia: Proliferative and Apoptotic Profile on Lymph Node, Studied by Immunohistochemistry Including the Proliferation Centers

Sotirios P. Sachanas, MD, Georgia Levidou, MD, Maria K. Angelopoulou, Maria Moschogiannis, MD, Xanthi Yiakoumis, MD, Theodoros P. Vassilakopoulos, Flora Kontopidou, Christina H. Kalpadakis, MD, Pantelis Tsirkinidis, Aglaia Dimitrakopoulou, Styliani Kokoris, Panayiotis Panayiotidis, Helen A. Papadaki, Eustratios Patsouris, Penelope Korkolopoulou, Gerassimos Pangalis

Blood (2011) 118 (21): 2538.

https://doi.org/10.1182/blood.V118.21.2538.2538

Published: 2011

Journal Articles

CD73-Generated Extracellular Adenosine Creates Microenvironmental Conditions Favoring Growth and Survival of Chronic Lymphocytic Leukemia Cells

Sara Serra, Alberto Horenstein, Tiziana Vaisitti, Davide Brusa, Davide Rossi, Luca Laurenti, Giovanni D'Arena, Marta Coscia, MD, PhD, Claudio Tripodo, Giorgio Inghirami, Simon Robson, Gianluca Gaidano, Fabio Malavasi, Silvia Deaglio

Blood (2011) 118 (21): 621.

https://doi.org/10.1182/blood.V118.21.621.621

Published: 2011

Journal Articles

Comparative Study of Peripheral Blood Morphology by Conventional Microscopy and Cellavision DM96 In Hematological and non Hematological Diseases

Anna Merino, MD, PhD, Rosa Brugues, MD, PhD, Rosario Garcia, Marta Kinder, Ferrán Torres, PhD, Gines Escolar, MD, PhD

Blood (2010) 116 (21): 4737.

https://doi.org/10.1182/blood.V116.21.4737.4737

Published: 2010

Journal Articles

Fludarabine Combination Therapy Response, Progression and Toxicity Profile in a Minority Predominant Population with Chronic Lymphocytic Leukemia from a Public Health Hospital

Bety Ciobanu, MD, Shylendra B Sreenivasappa, MD, Barbara Yim, Pharm.D, Tracy Smiley, RN, Victoria Angelova, MD, Paula Kovarik, MD, Samuel Ofori, MD, Mousami Shah, MD, Rafid Kouz, MD, Margaret Clare Telfer, MD, Rosalind Catchatourian, MD

Blood (2008) 112 (11): 4213.

https://doi.org/10.1182/blood.V112.11.4213.4213

Published: 2008

Journal Articles

Prognostic Value of β2-Microglobulin (β2M) Expression on Lymphocyte Surface in Chronic B-Lymphocytic Leukemia (B-CLL)

Maya Volkova, DM, Alvina A. Molodyk, Tatiana E. Bialik, Marina A. Frenkel

Blood (2008) 112 (11): 4192.

https://doi.org/10.1182/blood.V112.11.4192.4192

Published: 2008

Journal Articles

Retreatment with Alemtuzumab after a First, Successful Alemtuzumab Treatment in B-CLL.

Michael Fiegl, Florian Falkner, Andreas Falkner, Niklas Zojer, Michael Fridrik, Georg Hopfinger, Reinhard Stauder, Ebehard Gunsilius, Johanna Kantner, Martin Erdel, Inge Tinhofer, Guenther Gastl, Richard Greil, the Austrian Cooperation on MabCampath Use in CLL

Blood (2007) 110 (11): 4714.

https://doi.org/10.1182/blood.V110.11.4714.4714

Published: 2007

Journal Articles

Applying of Fludarabine in One Patient with CLL/PL Prolymphocytic Transformation - One Case Report.

XueFeng He, Ri Zhang, QinFen Ma, RuiFang Tao, DePei Wu

Blood (2005) 106 (11): 5035.

https://doi.org/10.1182/blood.V106.11.5035.5035

Published: 2005

Journal Articles

Complete Cytogenetic Response in a Case of T-PLL with a Complex Karyotype after Treatment with Alemtuzumab.

André F. Marinato, Fábio Morato de Oliveira, Rafael H. Jácomo, Edgar G. Rizzatti, Roberto P. Falcão, Eduardo M. Rego, Luiz G. Tone, Belinda P. Simões

Blood (2005) 106 (11): 4535.

https://doi.org/10.1182/blood.V106.11.4535.4535

Published: 2005

Journal Articles

B-Cell Prolymphocytic Leukemia (B-PLL) and Chronic Lymphocytic Leukemia (CLL) Express Distinct Genomic Profiles.

Ilaria Del Giudice, MD, Nnenna Osuji, MRCPath, Tim Dexter, PhD, Estella Matutes, FRCPath, Vasantha Brito-Babapulle, PhD, Nilima Parry-Jones, MD, Daniel Catovsky, FRCPath

Blood (2005) 106 (11): 4372.

https://doi.org/10.1182/blood.V106.11.4372.4372

Published: 2005

Journal Articles

Weighted Prognostic Models for Survival in Untreated and Previously Treated Patients with CLL.

William G. Wierda, MD, PhD, S. OBrien, MD, X. Wang, MS, A. Ferrajoli, MD, S. Faderl, MD, D. Thomas, MD, F. Ravandi, MD, K. Do, PhD, H. Kantarjian, MD, S. Lerner, MS, M. Keating, MD

Blood (2005) 106 (11): 5012.

https://doi.org/10.1182/blood.V106.11.5012.5012

Published: 2005

Journal Articles

Evolution of a True B-Cell Chronic Lymphocytic Leukaemia (B-CLL) in a Diffuse Immunocytoma after Treatment with Fludarabine.

Paolo Bernasconi, MD, Marco Paulli, MD, Ester Orlandi, MD, Vittorio Perfetti, MD, Ilaria Giardini, MD, Silvia Zibellini, MD, Laura Vanelli, MD, Annamaria Tenore, MD, Marina Boni, MD, Paola Maria Cavigliano, MD, Alessandra Algarotti, MD, Ercole Brusamolino, MD, Mario Lazzarino, MD

Blood (2005) 106 (11): 4973.

https://doi.org/10.1182/blood.V106.11.4973.4973

Published: 2005

NARROW

Splenic marginal zone lymphoma with increased prolymphocytes

Genetic Characterization of B-Cell Prolymphocytic Leukemia (B-PLL): A Hierarchical Prognostic Model Involving MYC and TP53 Abnormalities. on Behalf of the Groupe Francophone De Cytogenetique Hematologique (GFCH) and the French Innovative Leukemia Organization (FILO) Group

An Artificial Intelligence (AI) Approach for Automated Flow Cytometric Diagnosis of B-Cell Lymphoma

B-Cell Prolymphocytic Leukemia, a Rare Lymphoproliferative Disorder: Analysis of 35 Cases, a Study on Behalf of the French Innovative Leukemia Organization (FILO)

PD-1 Expression in Chronic Lymphocytic Leukemia and Large B-Cell Richter Transformation (DLBCL-RT): A Distinguishing Feature for DLBCL-RT and Promising Surrogate Marker for Clonal Relatedness

The Contribution of Gene Mutations to Long-Term Clinical Outcomes: Data from the Randomised UK LRF CLL4 Trial

Overcoming Ibrutinib Resitance In Relapsed Chronic Lymphocytic Leukemia

Diagnostic Value of CD200 Expression for the Differentiation Between Chronic Lymphocytic Leukemia (CLL), CLL with Increased Prolymphocytes (CLL/PL) and Mantle Cell Lymphoma.

Characteristics and Prognosis of Patients with Aggressive Chronic Lymphocytic Leukemia and Richter's Transformation: Correlation Between FDG/PET, Histology and Clinical Outcomes

Chronic Lymphocytic Leukemia: Proliferative and Apoptotic Profile on Lymph Node, Studied by Immunohistochemistry Including the Proliferation Centers

CD73-Generated Extracellular Adenosine Creates Microenvironmental Conditions Favoring Growth and Survival of Chronic Lymphocytic Leukemia Cells

Comparative Study of Peripheral Blood Morphology by Conventional Microscopy and Cellavision DM96 In Hematological and non Hematological Diseases

Fludarabine Combination Therapy Response, Progression and Toxicity Profile in a Minority Predominant Population with Chronic Lymphocytic Leukemia from a Public Health Hospital

Prognostic Value of β2-Microglobulin (β2M) Expression on Lymphocyte Surface in Chronic B-Lymphocytic Leukemia (B-CLL)

Retreatment with Alemtuzumab after a First, Successful Alemtuzumab Treatment in B-CLL.

Applying of Fludarabine in One Patient with CLL/PL Prolymphocytic Transformation - One Case Report.

Complete Cytogenetic Response in a Case of T-PLL with a Complex Karyotype after Treatment with Alemtuzumab.

B-Cell Prolymphocytic Leukemia (B-PLL) and Chronic Lymphocytic Leukemia (CLL) Express Distinct Genomic Profiles.

Weighted Prognostic Models for Survival in Untreated and Previously Treated Patients with CLL.

Evolution of a True B-Cell Chronic Lymphocytic Leukaemia (B-CLL) in a Diffuse Immunocytoma after Treatment with Fludarabine.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only